Alan R. Shuldiner
Regeneron (United States)(US)
Publications by Year
Research Areas
Genetic Associations and Epidemiology, Pancreatic function and diabetes, Adipose Tissue and Metabolism, Metabolism, Diabetes, and Cancer, Antiplatelet Therapy and Cardiovascular Diseases
Most-Cited Works
- → Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk(2011)2,057 cited
- → Newly identified loci that influence lipid concentrations and risk of coronary artery disease(2008)1,598 cited
- → Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy(2009)1,497 cited
- → Exome sequencing and analysis of 454,787 UK Biobank participants(2021)1,014 cited
- → Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits(2011)993 cited
- → Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update(2013)952 cited